Covid Live Updates: Omicron Helped Clarify Pfizer Vaccine Efficacy in Young Children, Gottlieb Says

The size of the U.S. wave has given regulators and scientists an opportunity to better assess vaccine efficacy in children aged 6 months to 4 years old, said Dr. Scott Gottlieb, who sits on the board of the vaccine maker Pfizer.